The drug risks of cilostazol: A pharmacovigilance study of FDA Adverse Event Reporting System database. Peng L, Li X, Li J, Liu S, et al. PLoS One 2024;19:e0314957.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Peng L, Li X, Li J, Liu S, et al. The drug risks of cilostazol: A pharmacovigilance study of FDA Adverse Event Reporting System database. PLoS One 2024;19:e0314957.
PMID: 39630707